ALNYLAM PHARMACEUTICALS, INC. (ALNY) Operating margin 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) operating margin by fiscal year — reported operating income divided by reported revenue.
13.5%FY2025 · since FY2016: -900.3% → 13.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.5% | +21.4 pp |
| FY2024 | -7.9% | +7.6 pp |
| FY2023 | -15.4% | +60.2 pp |
| FY2022 | -75.7% | +8.3 pp |
| FY2021 | -83.9% | +84.2 pp |
| FY2020 | -168.1% | +259.4 pp |
| FY2019 | -427.5% | +660.1 pp |
| FY2018 | -1087.6% | -531.4 pp |
| FY2017 | -556.2% | +344.1 pp |
| FY2016 | -900.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice